Literature DB >> 25518708

B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis.

Vuslat Yilmaz1, Piraye Oflazer, Fikret Aysal, Yeşim G Parman, Haner Direskeneli, Feza Deymeer, Güher Saruhan-Direskeneli.   

Abstract

B cells from myasthenia gravis (MG) patients with autoantibodies (Aab) against acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or with no detectable Aab were investigated as cytokine producing cells in this study. B cells were evaluated for memory phenotypes and expressions of IL-10, IL-6 and IL-12A. Induced productions of IL-10, IL-6, IL-12p40, TNF-α and LT from isolated B cells in vitro were measured by immunoassays. MG patients receiving immunosuppressive treatment had higher proportions of memory B cells compared with healthy controls and untreated patients. With CD40 stimulation MG patients produced significantly lower levels of IL-10, IL-6. With CD40 and B cell receptor stimulation of B cells, TNF-α production also decreased in addition to these cytokines. The lower levels of these cytokine productions were not related to treatment. Our results confirm a disturbance of B cell subpopulations in MG subgroups on immunosuppressive treatment. B cell derived IL-10, IL-6 and TNF-α are down-regulated in MG, irrespective of different antibody productions. Ineffective cytokine production by B cells may be a susceptibility factor in dysregulation of autoimmune Aab production.

Entities:  

Keywords:  Autoantibody; B cell; cytokine; myasthenia gravis

Mesh:

Substances:

Year:  2014        PMID: 25518708     DOI: 10.3109/08916934.2014.992517

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

Review 1.  IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders.

Authors:  Maartje G Huijbers; Jaap J Plomp; Silvère M van der Maarel; Jan J Verschuuren
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

Review 2.  Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.

Authors:  A Uzawa; S Kuwabara; S Suzuki; T Imai; H Murai; Y Ozawa; M Yasuda; Y Nagane; K Utsugisawa
Journal:  Clin Exp Immunol       Date:  2020-12-03       Impact factor: 5.732

3.  Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.

Authors:  Vuslat Yilmaz; Piraye Oflazer; Fikret Aysal; Hacer Durmus; Kostas Poulas; Sibel P Yentur; Yesim Gulsen-Parman; Socrates Tzartos; Alexander Marx; Erdem Tuzun; Feza Deymeer; Güher Saruhan-Direskeneli
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

4.  Changes in inflammatory cytokine networks in myasthenia gravis.

Authors:  Akiyuki Uzawa; Tetsuya Kanai; Naoki Kawaguchi; Fumiko Oda; Keiichi Himuro; Satoshi Kuwabara
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 5.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

Review 6.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

Review 7.  IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Authors:  Inga Koneczny; John Tzartos; Marina Mané-Damas; Vuslat Yilmaz; Maartje G Huijbers; Konstantinos Lazaridis; Romana Höftberger; Erdem Tüzün; Pilar Martinez-Martinez; Socrates Tzartos; Frank Leypoldt
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

8.  Oral Microbiota Profile in a Group of Anti-AChR Antibody-Positive Myasthenia Gravis Patients.

Authors:  Chao Huang; Feng Gao; Haitao Zhou; Li Zhang; Dandan Shang; Ying Ji; Zhihui Duan
Journal:  Front Neurol       Date:  2022-07-07       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.